Company Vycor Medical, Inc. Other OTC
Equities
VYCO
US92921M2035
Medical Equipment, Supplies & Distribution
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Vycor Medical
94.4
%
| 1 | 92.5 % | 1 | 94.4 % | +21.90% |
NovaVision
5.6
%
| 0 | 7.5 % | 0 | 5.6 % | -10.93% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
99.5
%
| 1 | 99.3 % | 1 | 99.5 % | +19.69% |
Europe
0.5
%
| 0 | 0.7 % | 0 | 0.5 % | -18.84% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Peter Zachariou
CEO | Chief Executive Officer | 62 | 10-05-13 |
President | 57 | 09-12-31 | |
Chairman | 65 | 09-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Zachariou
CEO | Chief Executive Officer | 62 | 10-05-13 |
Chairman | 65 | 09-12-31 | |
President | 57 | 09-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 32,732,169 | 12,239,459 ( 37.39 %) | 103,334 ( 0.3157 %) | 37.09 % |
Stock B | 0 | 270,306 | 0 | 0 |
Company contact information
Vycor Medical, Inc.
951 Broken Sound Boulevard Suite 320
33487, Boca Raton
+
http://www.vycormedical.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-2.92% | 185B | |
-3.80% | 107B | |
-5.48% | 67.55B | |
+11.22% | 54.6B | |
+16.74% | 47.42B | |
+3.86% | 42.24B | |
+4.56% | 28.24B | |
+1.64% | 26.42B | |
+12.40% | 25.66B |